Veronika Dubajova: A Leading Force in Medical Technology and Healthcare Services Research at Citi
In the rapidly evolving world of medical technology and healthcare services, Veronika Dubajova stands as one of the most influential voices in financial research. As the Managing Director at Citi, she leads the Medical Technology and Healthcare Services Research division for the EMEA region. With an impressive career spanning over 15 years, including significant roles at Goldman Sachs, Dubajova has carved out a niche as a leading expert in healthcare investment analysis.
Her work is not just limited to tracking market trends but extends into providing insights that shape the future of healthcare investing. This article takes a deeper dive into the career, achievements, and impact of Veronika Dubajova, while exploring her growing influence in the medical technology sector and the broader tech landscape.
Early Career and Education: Laying the Foundation
Veronika Dubajova’s journey to success began at Swarthmore College, where she earned her Bachelor of Arts in Economics and Political Science. Her academic background provided a solid foundation for her future in financial research, particularly in sectors requiring both analytical and strategic thinking.
Upon graduation, Veronika ventured into the pharmaceutical and healthcare industries, where her interest in medical technology began to take shape. She worked in business development at Arriva Pharmaceuticals, a role that exposed her to the nuances of the healthcare sector. Her time at Goldman Sachs, which spanned over 12 years, truly established her as an expert in European MedTech and Healthcare Services, laying the groundwork for her current position at Citi.
Transition to Citi: A New Chapter
In August 2022, Veronika Dubajova transitioned to Citi, one of the largest financial institutions globally. As the Managing Director and Head of Medical Technology and Healthcare Services Research, she has been instrumental in providing critical research on healthcare companies and investments across the EMEA region. In this role, Dubajova’s deep knowledge of MedTech markets helps guide investors through complex challenges and opportunities in the healthcare sector.
Her transition to Citi represents a significant shift from her previous role at Goldman Sachs, but it highlights her ability to adapt to and lead in diverse financial environments. As an expert on healthcare investment, her work influences how investors view medical technology companies, helping them navigate an increasingly volatile market.
Veronika Dubajova’s Role in Shaping Healthcare Investment
One of Veronika’s key strengths lies in her ability to offer in-depth, forward-thinking analysis of the healthcare and medical technology sectors. Her research focuses not only on financial returns but also on emerging technologies, regulatory shifts, and healthcare trends that are likely to disrupt or enhance the landscape.
Medical Technology Investment
In her current position at Citi, Veronika Dubajova leads a team that specializes in MedTech, analyzing both established players and innovative startups in the healthcare space. She tracks industry leaders and emerging technologies in sectors such as diagnostics, medical devices, and healthcare IT systems. As healthcare is increasingly integrated with advanced technology, her research has become indispensable for investors looking to gain insights into market opportunities.
Dubajova’s team provides extensive market reports, forecasting growth trajectories for key companies and identifying trends that will shape the future of healthcare. This type of research is vital as the MedTech industry evolves, with new innovations in robotics, artificial intelligence, and biotechnology driving change across the globe.
Healthcare Services Research
In addition to her focus on MedTech, Dubajova’s research encompasses healthcare services, which are experiencing rapid transformation due to technology. As a result, the lines between traditional healthcare providers and technology companies are becoming increasingly blurred. With new business models such as telemedicine, virtual health platforms, and AI-driven diagnostics, the way healthcare is delivered is undergoing significant change. Veronika Dubajova’s insights help investors understand how these shifts will impact both established healthcare companies and new market entrants.
Her work provides a comprehensive view of healthcare systems, examining the financial viability of emerging health tech solutions, regulatory environments, and the evolving role of private and public-sector investments in healthcare services.
Veronika Dubajova’s Impact on Global Healthcare Trends
Antimicrobial Resistance (AMR)
One of the global healthcare challenges that Veronika Dubajova has worked on extensively is antimicrobial resistance (AMR). In 2022, she co-authored a Citi GPS (Global Perspectives & Solutions) report that highlighted AMR as a growing public health crisis with potentially catastrophic economic implications. AMR occurs when bacteria evolve to resist the effects of medications that once killed them, leading to the rise of “superbugs” that can no longer be treated with existing antibiotics.
Dubajova’s research explores how AMR intersects with climate change, infectious disease burden, and global health policies. Her work advocates for sustainable investment practices in healthcare, aiming to prevent the spread of AMR through smarter healthcare solutions and more responsible use of antimicrobial agents. In this context, her work bridges the gap between finance and public health, aligning the interests of investors with global healthcare goals.
Environmental Factors in Healthcare
As a forward-thinking leader in healthcare research, Veronika Dubajova also examines the impact of climate change on public health. Her work highlights how extreme weather events and pathogen exchange are linked to the spread of infectious diseases and antibiotic resistance. These insights are crucial for investors and policymakers seeking to understand how environmental challenges will shape healthcare delivery and technological advancements in the years to come.
Her contributions in this space have earned her recognition not just within the finance community but among health policy experts as well. By linking financial trends with healthcare’s most pressing issues, Dubajova ensures that investors are well-positioned to navigate an increasingly interconnected world.
Veronika Dubajova: A Voice in the TechUK and EMEA Healthcare Tech Community
In addition to her professional work, Veronika Dubajova has become a key figure within the techUK community. Through her engagement with techUK, Dubajova helps promote the integration of technology in the healthcare sector, ensuring that innovations such as AI, big data, and healthcare IT systems continue to receive investment and attention from both the private sector and governmental bodies.
Her participation in key events, including Citi’s Healthcare & MedTech Conference, provides a platform for discussing emerging technologies in healthcare. These discussions often involve leaders from both the healthcare and technology sectors, showcasing Dubajova’s unique role in bridging the two industries.
Conclusion: Veronika Dubajova’s Lasting Legacy
Veronika Dubajova’s career is defined by her ability to blend finance with healthcare, providing investors and stakeholders with the tools needed to navigate the complexities of a sector in constant evolution. As Managing Director at Citi, she has become a key player in shaping the future of MedTech and healthcare services, providing essential research that informs both investors and policymakers. Her commitment to addressing critical issues like antimicrobial resistance, climate change, and technology integration highlights her forward-thinking approach to the healthcare industry.
For anyone looking to understand the future of healthcare investment and the crucial role of technology in transforming healthcare systems, Veronika Dubajova is a name to watch.
